China's Yunfeng, TF Capital back take-private deal of biotech firm CBMG

China's Yunfeng, TF Capital back take-private deal of biotech firm CBMG

Source: CBMG LinkedIn

13 August, 2020

biopharmaceutical Cellular Biomedicine Group NASDAQ TF Capital Yunfeng Capital

Printed by Unregistered user on Sun, 10 Aug 2025 05:26:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

PE firm Hillhouse’s big biotech bet hits roadblock amid tightening rules

Chinese retailer Suning injects $129m in Jack Ma's Yunfeng Capital fund

Read more from Greater China

High-profile Chinese dealmaker Bao Fan released from detention after two years

Policy & Regulations

China tells brokers to halt endorsements of stablecoin